David W. Nelson

David W. Nelson

Auto-generated profile, based on publicly available information

David W. Nelson

Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2017 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
ETEric Thelin
Eric Thelin
DNDavid W Nelson
David W Nelson
JVJuho Vehviläinen
Juho Vehviläinen
HNHarriet Nyström
Harriet Nyström
RKRiku Kivisaari
Riku Kivisaari
RRRaj Rahul
Raj Rahul
Background: Traumatic brain injury (TBI) is a major contributor to morbidity and mortality. Computerized tomography (CT) scanning of the brain is essential for diagnostic screening of intracranial injuries in need of neurosurgical intervention, but may also provide information concerning patient prognosis and enable baseline risk stratification in clinical trials. Novel CT scoring systems have been developed to improve current prognostic models, including the Stockholm and Helsinki CT scores, but so far have not been extensively validated. The primary aim of this study was to evaluate the Stockholm and Helsinki CT scores for predicting functional outcome, in comparison with the Rotterdam CT score and Marshall CT classification. The secondary aims were to assess which individual components of the CT scores best predict outcome and what additional prognostic value the CT scoring systems contribute to a clinical prognostic model. Methods and findings: TBI patients requiring neuro-intensive care and not included in the initial creation of the Stockholm and Helsinki CT scoring systems were retrospectively included from prospectively collected data at the Karolinska University Hospital (n = 720 from 1 January 2005 to 31 December 2014) and Helsinki University Hospital (n = 395 from 1 January 2013 to 31 December 2014), totaling 1,115 patients. The Marshall CT classification and the Rotterdam, Stockholm, and Helsinki CT scores were assessed using the admission CT scans. Known outcome predictors at admission were acquired (age, pupil responsiveness, admission Glasgow Coma Scale, glucose level, and hemoglobin level) and used in univariate, and multivariable, regression models to predict long-term functional outcome (dichotomizations of the Glasgow Outcome Scale [GOS]). In total, 478 patients (43%) had an unfavorable outcome (GOS 1–3). In the combined cohort, overall prognostic performance was more accurate for the Stockholm CT score (Nagelkerke’s pseudo-R2 range 0.24–0.28) and the Helsinki CT score (0.18–0.22) than for the Rotterdam CT score (0.13–0.15) and Marshall CT classification (0.03–0.05). Moreover, the Stockholm and Helsinki CT scores added the most independent prognostic value in the presence of other known clinical outcome predictors in TBI (6% and 4%, respectively). The aggregate traumatic subarachnoid hemorrhage (tSAH) component of the Stockholm CT score was the strongest predictor of unfavorable outcome. The main limitations were the retrospective nature of the study, missing patient information, and the varying follow-up time between the centers. Conclusions: The Stockholm and Helsinki CT scores provide more information on the damage sustained, and give a more accurate outcome prediction, than earlier classification systems. The strong independent predictive value of tSAH may reflect an underrated component of TBI pathophysiology. A change to these newer CT scoring systems may be warranted.

1 April 2020 in Journal of Neurotrauma
Verified
Journal Article
Open access
BGBenjamin Gravesteijn
Benjamin Gravesteijn
CSCharlie Sewalt
Charlie Sewalt
AEAri Ercole
Ari Ercole
CACecilia Akerlund
Cecilia Akerlund
DNDavid Nelson
David Nelson
ESEwout W Steyerberg
Ewout W Steyerberg
Traumatic brain injury (TBI) is currently classified as mild, moderate or severe TBI by trichotomizing the Glasgow coma scale (GCS). We aimed to explore directions for a more refined multidimensional classification system. For that purpose, we performed a hypothesis-free cluster analysis in the CENTER-TBI database: a European all-severity TBI cohort (n=4509). The first building block consisted of key imaging characteristics, summarized using principal component analysis from 12 imaging characteristics. The other building blocks were demographics, clinical severity, secondary insults, and cause of injury. With these building blocks, the patients were clustered into four groups. We applied bootstrap resampling with replacement to study the stability of cluster allocation. The characteristics which predominantly defined the clusters were injury cause, major extracranial injury, and GCS. The clusters consisted of 1451, 1534, 1006, and 518 patients, respectively. The clustering method was quite stable: the proportion of patients staying in one cluster after resampling and reclustering was 97.4% (95% CI:85.6%-99.9%). These clusters characterised groups of patients with different functional outcomes: from mild to severe, 12%, 19%, 36%, and 58% of patients had unfavourable six-month outcome. Compared to the mild and the upper intermediate cluster, the lower intermediate and the severe cluster received more key interventions. To conclude, four types of TBI patients may be defined by injury mechanism, presence of major extracranial injury and GCS. Describing patients according to these three characteristics could potentially capture differences in etiology and care pathways better than with GCS only.

13 April 2026 in Critical Care
Verified
Journal Article
Open access
PDF file
AHAdel Helmy
Adel Helmy
MBMichael S. Baker
Michael S. Baker
PCPatrick M. Chen
Patrick M. Chen
AQAoife Quinn
Aoife Quinn
IJIbrahim Jalloh
Ibrahim Jalloh
PHPeter John Ashton Hutchinson
Peter John Ashton Hutchinson
Purpose: Secondary brain injury is a common cause of poor outcome after trauma, subarachnoid hemorrhage, and intracerebral hemorrhage, and optimizing treatment requires real-time insight into cerebral metabolism. Cerebral microdialysis (CMD) uniquely provides key related information, yet consensus on its use has not been updated since publication of the consensus statement from the 2014 International Microdialysis Forum. We aimed to assess expert consensus on the use of CMD in critical care and provide contemporary guidance to standardize practice and advance clinical implementation. Methods: We conducted a 3-round modified Delphi study with international experts in CMD and neurocritical care. Consensus was defined as ≥ 75% agreement among non-abstaining respondents, with a minimum of 30 non-abstaining respondents required per statement. Statements not reaching consensus were iteratively revised based on panelist feedback. Results: Forty of 67 invited experts (60%) from 9 countries participated. Sixty of 62 individual items achieved consensus (97%) across 9 domains: indications and patient selection, technical and procedural considerations, detecting deterioration and secondary injury, metabolic interpretation, treatment algorithms, glucose management, sampling frequency, core reporting items, and barriers to clinical implementation. Conclusion: This consensus statement provides updated, evidence-informed recommendations for the use of CMD in critical care. The panel reaffirmed many core recommendations from the 2014 consensus while making targeted advances: cautious extension of guidance to intracerebral hemorrhage, comprehensive reporting guidance addressing frequently omitted elements (19 items vs. 6 in 2014), and identification of 10 key barriers to routine clinical adoption.

15 May 2024 in medRxiv
Verified
Preprint
Open access
PDF file
SBShubhayu Bhattacharyay
Shubhayu Bhattacharyay
FLFlorian D van Leeuwen
Florian D van Leeuwen
EBErta Beqiri
Erta Beqiri
CÅCecilia Åkerlund
Cecilia Åkerlund
LWLindsay Wilson
Lindsay Wilson
PAParticipants
Participants
Practices for controlling intracranial pressure (ICP) in traumatic brain injury (TBI) patients admitted to the intensive care unit (ICU) vary considerably between centres. To help understand the rational basis for such variance in care, this study aims to identify the patient-level predictors of changes in ICP management. We extracted all heterogeneous data (2,008 pre-ICU and ICU variables) collected from a prospective cohort ( n =844, 51 ICUs) of ICP-monitored TBI patients in the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study. We developed the TILTomorrow modelling strategy, which leverages recurrent neural networks to map a token-embedded time series representation of all variables (including missing values) to an ordinal, dynamic prediction of the following day’s five-category therapy intensity level (TIL (Basic) ) score. With 20 repeats of 5-fold cross-validation, we trained TILTomorrow on different variable sets and applied the TimeSHAP (temporal extension of SHapley Additive exPlanations) algorithm to estimate variable contributions towards predictions of next-day changes in TIL (Basic) . Based on Somers’ D xy , the full range of variables explained 68% (95% CI: 65–72%) of the ordinal variation in next-day changes in TIL (Basic) on day one and up to 51% (95% CI: 45–56%) thereafter, when changes in TIL (Basic) became less frequent. Up to 81% (95% CI: 78–85%) of this explanation could be derived from non-treatment variables (i.e., markers of pathophysiology and injury severity), but the prior trajectory of ICU management significantly improved prediction of future de-escalations in ICP-targeted treatment. Whilst there was no significant difference in the predictive discriminability (i.e., area under receiver operating characteristic curve [AUC]) between next-day escalations (0.80 [95% CI: 0.77–0.84]) and de-escalations (0.79 [95% CI: 0.76– 0.82]) in TIL (Basic) after day two, we found specific predictor effects to be more robust with de-escalations. The most important predictors of day-to-day changes in ICP management included preceding treatments, age, space-occupying lesions, ICP, metabolic derangements, and neurological function. Serial protein biomarkers were also important and may serve a useful role in the clinical armamentarium for assessing therapeutic needs. Approximately half of the ordinal variation in day-to-day changes in TIL (Basic) after day two remained unexplained, underscoring the significant contribution of unmeasured factors or clinicians’ personal preferences in ICP treatment. At the same time, specific dynamic markers of pathophysiology associated strongly with changes in treatment intensity and, upon mechanistic investigation, may improve the timing and personalised targeting of future care.

8 August 2023 in medRxiv
Verified
Preprint
Open access
PDF file
SBShubhayu Bhattacharyay
Shubhayu Bhattacharyay
EBErta Beqiri
Erta Beqiri
PZPatrick Zuercher
Patrick Zuercher
LWLindsay Wilson
Lindsay Wilson
ESEwout W Steyerberg
Ewout W Steyerberg
PAParticipants
Participants
Intracranial pressure (ICP) data from traumatic brain injury (TBI) patients in the intensive care unit (ICU) cannot be interpreted appropriately without accounting for the effect of administered therapy intensity level (TIL) on ICP. A 15-point scale was originally proposed in 1987 to quantify the hourly intensity of ICP-targeted treatment. This scale was subsequently modified – through expert consensus – during the development of TBI Common Data Elements to address statistical limitations and improve usability. The latest, 38-point scale (hereafter referred to as TIL) permits integrated scoring for a 24- hour period and has a five-category, condensed version (TIL (Basic) ) based on qualitative assessment. Here, we perform a total- and component-score analysis of TIL and TIL (Basic) to: (1) validate the scales across the wide variation in contemporary ICP management, (2) compare their performance against that of predecessors, and (3) derive guidelines for proper scale use. From the observational Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, we extract clinical data from a prospective cohort of ICP-monitored TBI patients ( n =873) from 52 ICUs across 19 countries. We calculate daily TIL and TIL (Basic) scores (TIL 24 and TIL (Basic) 24 , respectively) from each patient’s first week of ICU stay. We also calculate summary TIL and TIL (Basic) scores by taking the first-week maximum (TIL max and TIL (Basic) max ) and first-week median (TIL median and TIL (Basic) median ) of TIL 24 and TIL (Basic) 24 scores for each patient. We find that, across all measures of construct and criterion validity, the latest TIL scale performs significantly greater than or similarly to all alternative scales (including TIL (Basic) ) and integrates the widest range of modern ICP treatments. TIL median outperforms both TIL max and summarised ICP values in detecting refractory intracranial hypertension (RICH) during ICU stay. The RICH detection thresholds which maximise the sum of sensitivity and specificity are TIL median ≥7.5 and TIL max ≥14. The TIL 24 threshold which maximises the sum of sensitivity and specificity in the detection of surgical ICP control is TIL 24 ≥9. The median scores of each TIL component therapy over increasing TIL 24 reflect a credible staircase approach to treatment intensity escalation, from head positioning to surgical ICP control, as well as considerable variability in the use of cerebrospinal fluid drainage and decompressive craniectomy. Since TIL (Basic) max suffers from a strong statistical ceiling effect and only covers 17% (95% CI: 16–18%) of the information in TIL max , TIL (Basic) should not be used instead of TIL for rating maximum treatment intensity. TIL (Basic) 24 and TIL (Basic) median can be suitable replacements for TIL 24 and TIL median , respectively (with up to 33% [95% CI: 31–35%] information coverage) when TIL assessment is infeasible. Accordingly, we derive numerical ranges for categorising TIL 24 scores into TIL (Basic) 24 scores. In conclusion, our results validate TIL across a spectrum of ICP management and monitoring approaches. TIL is a more sensitive surrogate for pathophysiology than ICP and thus can be considered an intermediate outcome after TBI.